Altamonte Springs, Fla.-based AdventHealth recorded an operating income of $589.1 million (10.3% operating margin) in the third quarter of 2025, compared to an operating income of $590.4 million (11.8% margin) during the same period last year, according to its most recent financial report.
AdventHealth reported total operating revenue of $5.7 billion for the three months ended Sept. 30, up from $5 billion during the same period last year. Net patient service revenue was $5.4 billion, up from $4.7 billion.
Total operating expenses were $5.1 billion, up from $4.4 billion during the same period last year. Employee compensation expenses totaled $2.7 billion, up from $2.4 billion. Supply costs were $885.1 million, up from $723.9 million. Professional fees were $380.1 million, up from $276.6 million.
The system had 257 days cash on hand as of Sept. 30, up from 243 on June 30.
AdventHealth reported a net income of $1.2 billion in the third quarter, up from $1 billion during the same period last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
